Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Obstr Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT01043601
What this trial is testing

Efficacy and Safety of Two Doses of Formoterol Fumarate MDI (PT005) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), Compared to Foradil® Aerolizer® as an Active Control

Who this might be right for
COPD
Pearl Therapeutics, Inc.
Early research (Phase 1)Study completedNCT00783107
What this trial is testing

Aerosol Cyclosporine in Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
University of Pittsburgh 8
Early research (Phase 1)Study completedNCT02512302
What this trial is testing

Study to Determine the Amount of Glycopyrrolate Absorbed in the Lungs After Taking the Medicine With a eFlow Nebulizer and Seebri® Breezhaler® With and Without Activated Charcoal in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).

Who this might be right for
COPD
Sunovion Respiratory Development Inc. 30
Early research (Phase 1)Study completedNCT02180919
What this trial is testing

Implementation of Telemonitoring in Chronic Heart or Lung Failure

Who this might be right for
COPDHeart FailureRespiratory Failure
Royal Brompton & Harefield NHS Foundation Trust 85
Large-scale testing (Phase 3)Study completedNCT03843541
What this trial is testing

A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions

Who this might be right for
Respiratory Tract DiseasesAbnormal Mucus Secretions
Zambon SpA 333
Large-scale testing (Phase 3)WithdrawnNCT00716053
What this trial is testing

Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) Emphysema

Who this might be right for
Advanced Upper Lobe Predominant Emphysema
Aeris Therapeutics 225
Not applicableUnknownNCT05174741
What this trial is testing

Pulmonary Rehabilitation in Non-chronic Obstructive Pulmonary Disease Patients.

Who this might be right for
PneumoniaPulmonary FibrosisTuberculosis+2 more
Riphah International University 20
Not applicableStudy completedNCT02347566
What this trial is testing

Physical Activity Enhancing Programme in COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
University of Edinburgh 46
Large-scale testing (Phase 3)Study completedNCT03095456
What this trial is testing

Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease, COPDLow Peak Inspiratory Flow Rate (PIFR)
Mylan Inc. 207
Large-scale testing (Phase 3)Study completedNCT02207829
What this trial is testing

A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 1,017
Not applicableStudy completedNCT02007772
What this trial is testing

Effectiveness of TNI vs. BiPAP in Chronic Global Insufficiency in COPD Patients

Who this might be right for
COPD Chronic Obstructive Pulmonary Disease
University of Leipzig 105
Testing effectiveness (Phase 2)UnknownNCT04011930
What this trial is testing

This Study Include Chronic Obstructive Pulmonary Disease(COPD) Patients . Patients Were Vitamin D Deficient Age Range 40 to 80 Years, Smokers Patients Were Advised to Take Either Placebo or Vitamin D3 . Antioxidant Enzymes Were Assessed at Baseline and at 26th Weeks.

Who this might be right for
Chronic Obstructive Pulmonary Disease
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 40
Not applicableUnknownNCT04259736
What this trial is testing

Prospective Cohort Study of Molecular Mechanism of Lower Respiratory Tract Microbes in Patients With AECOPD

Who this might be right for
Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseMicrobiome
Huashan Hospital 50
Not applicableUnknownNCT04432194
What this trial is testing

Effect of Nutritional Supplementation and Pulmonary Rehabilitation on the Clinical Status of HF and COPD

Who this might be right for
Heart FailureCopdNutritional Supplementation+1 more
Instituto Nacional de Enfermedades Respiratorias 100
Not applicableStudy completedNCT04791267
What this trial is testing

ENCOMPASS: Expansion Study C

Who this might be right for
HypertensionDiabetes Mellitus, Type 2Chronic Kidney Diseases+4 more
University of Calgary 61
Not applicableEnded earlyNCT03694431
What this trial is testing

Comparative Trial of Home-Based Palliative Care

Who this might be right for
CancerChronic Obstructive Pulmonary DiseaseHeart Failure+4 more
Kaiser Permanente 3,999
Not applicableStudy completedNCT00151372
What this trial is testing

Treatment of Depressed Chronic Obstructive Pulmonary Disease Patients

Who this might be right for
Pulmonary Disease, Chronic ObstructiveMajor Depression
Weill Medical College of Cornell University 141
Not applicableStudy completedNCT01216592
What this trial is testing

Airway Inflammation, Symptoms and Lung Function in COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Università degli Studi di Ferrara 40
Not applicableStudy completedNCT02370654
What this trial is testing

Chen-style Tai Chi in Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Laval University 44
Not applicableNot Yet RecruitingNCT07430605
What this trial is testing

WearME-Pro Phase II: Remote Use Usability and Longitudinal Validation Study (Patch Form Factor).

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
LASARRUS Clinic and Research Center 82
Next Page